These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Cellular hypersensitivity to intestinal mucosa components in ulcerative colitis and Chrohn's disease. Bendixen G Tijdschr Gastroenterol; 1970; 13(6):459-66. PubMed ID: 5519339 [No Abstract] [Full Text] [Related]
6. [Antibodies against Escherichia coli in ulcerous colitis]. Anselm K; LoGrippo GA; Hayashi H Z Gastroenterol; 1971; 9(9):648-50. PubMed ID: 4949181 [No Abstract] [Full Text] [Related]
7. [Cellular immunity in neoplasms. Comparative study with alcoholic agressive chronic hepatitis and ulcerative colitis]. Sánchez Cousteau JA; Justo Alpañes E; Pellicer Bautista F; Olivan J; Ledro Molina D; Valle Bernal J; Ramírez RL; Silverio M; Rada R; Ferreiro M; Garrido Peralta M Rev Clin Esp; 1979 Jan; 152(1):27-31. PubMed ID: 424631 [No Abstract] [Full Text] [Related]
8. Circulating antibodies to the surface antigens on colon epithelial cells in ulcerative colitis. Hibi T; Aiso S; Ishikawa M; Watanabe M; Yoshida T; Kobayashi K; Asakura H; Tsuru S; Tsuchiya M Clin Exp Immunol; 1983 Oct; 54(1):163-8. PubMed ID: 6352104 [TBL] [Abstract][Full Text] [Related]
9. Manipulating T regulatory cells for cure of ulcerative colitis: ground zero in crosshairs. Ahuja V Trop Gastroenterol; 2007; 28(1):1-3. PubMed ID: 17896601 [No Abstract] [Full Text] [Related]
10. [Changes in the liver in chronic ulcerative, hemorrhagic colitis]. Dzhadzhova-Boneva M; Velev G; Ianchev V; Etŭrska M; Stoĭnov S Vutr Boles; 1980; 19(4):31-5. PubMed ID: 7415157 [No Abstract] [Full Text] [Related]
11. [Characteristics of the disorders of the T chain of the immune system in nonspecific ulcerative colitis and their significance in choosing effective therapy]. Shakhnazarov AA Ter Arkh; 1984; 56(2):106-8. PubMed ID: 6608803 [No Abstract] [Full Text] [Related]
12. Immunologic manifestations of healthy consanguineous relatives of patients suffering from ulcerative colitis. Polcak J; Skalova M Am J Proctol; 1968 Jun; 19(3):197-203. PubMed ID: 5659139 [No Abstract] [Full Text] [Related]
13. HLA antigens and pANCA define ulcerative colitis as a genetically heterogeneous disorder. Perri F; Annese V; Piepoli A; Napolitano G; Lombardi G; Ciavarella G; Di Giorgio G; Andriulli A Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):56-61. PubMed ID: 9615268 [TBL] [Abstract][Full Text] [Related]
14. [Changes in the indices of cellular and humoral immunity in patients with gastrointestinal ulcer]. Perederiĭ VG; Shakhnazarov AA Vrach Delo; 1983 Aug; (8):83-5. PubMed ID: 6605623 [No Abstract] [Full Text] [Related]
18. Characterization of immunoregulatory T cells and lymphocytophilic antibodies in ulcerative colitis: analysis with monoclonal antibodies. Aiso S; Watanabe M; Hibi T; Yoshida T; Tsuchiya M; Tsuru S J Clin Lab Immunol; 1982 Nov; 9(2):109-12. PubMed ID: 6984077 [TBL] [Abstract][Full Text] [Related]
19. Development of ulcerative colitis-associated anti-idiotype antibody using a novel monoclonal antibody against a colonic autoantigen. Shah U; Dasgupta A; Das KM Cell Immunol; 1995 Nov; 166(1):154-7. PubMed ID: 7585975 [TBL] [Abstract][Full Text] [Related]
20. Defects in mucosal immunity leading to ulcerative colitis. Targan SR; Karp LC Immunol Rev; 2005 Aug; 206():296-305. PubMed ID: 16048556 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]